Please login to the form below

Not currently logged in
Email:
Password:

bioelectronic medicines

This page shows the latest bioelectronic medicines news and features for those working in and with pharma, biotech and healthcare.

GSK and Google launch bioelectronics venture

GSK and Google launch bioelectronics venture

GlaxoSmithKline has joined forces with Google's Verily Life Sciences to establish a new company dedicated to the development of bioelectronic medicines. ... Bioelectronic medicine is concerned with the electrical signals firing between the body's nervous

Latest news

  • GSK expands bioelectronics efforts with $5m challenge fund GSK expands bioelectronics efforts with $5m challenge fund

    GlaxoSmithKline (GSK) is setting up a $5m fund for external researchers working in the area of bioelectronic medicines, boosting its investment in the emerging technology. ... GSK was the first big pharma company to make a significant investment in

  • Electric dreams in medicine Electric dreams in medicine

    year and following that up with funding to support up to 20 research projects in the field and a $50m venture capital fund to support companies with bioelectronic medicines and technologies. ... companies are developing electronic devices that could add

  • GSK invests $50m in 'bioelectronic' medicines GSK invests $50m in 'bioelectronic' medicines

    GSK invests $50m in 'bioelectronic' medicines. Will support research investigating use of electrical signals in nerves to help treat diseases. ... GSK said that SetPoint's investigational device had “ important hallmarks of future bioelectronic

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics